Poulvac IBMM + ARK
Active substance
ATC code
Species
Chickens (broilers).
Indications
For the active immunisation of broilers to reduce the severity of upper respiratory tract infections caused by Massachusetts and 793/B/91-type strains of avian infectious bronchitis virus.
Onset of immunity: 21 days after vaccination
Duration of immunity: 6 weeks after vaccination
Protection has also been demonstrated in the presence of maternally derived antibodies.
Dose to be administered and administration route
One dose of vaccine per bird by spray administration (oculonasal use) from one day of age.
This vaccine has been used in most types of spray equipment handsprayers (e.g. ASL
Polyspray 2), knapsack sprayers (e.g. Birchmeyer with 0.55 or 1.6 mm spray nozzle, Gloria with 1.0 mm nozzle) or automatic spraying equipment (e.g. Bimex). The apparatus should be set to deliver a coarse spray (droplet size of 80-160 micrometres), allowing a dose of 0.5 ml per bird.
The lyophilised vaccine should be reconstituted with water of good quality at room temperature e.g. deionised water or good quality drinking water.
The lyophilised vaccine should be reconstituted as follows:
Remove the aluminium cap from the vial. To reconstitute the lyophilised vaccine, the rubber stopper should be removed whilst the vial is immersed in a plastic measuring jug containing 0.5 litre of clean cool water.
Half fill the vial with water, replace the stopper and shake to remove any remnants in the vial.
The content of the vial should then be added to the water in the jug, mixed well and transferred to the sprayer tank and thoroughly mixed. For the 5,000 dose vial a total amount of 2.5 l water is required and for the 10,000 dose vial a total amount of 5 l water should be used.
The chickens should be sprayed in chick boxes or brooding rings in the house to avoid loss of vaccine virus.
Upon reconstitution, transparent to white opaque suspension (depending on the volume of water used).
Adverse reactions
Chickens (broilers):
|
Common (1 to 10 animals / 100 animals treated): |
Respiratory signs (including gasping, snicking and raling)1 |
1Generally mild; may be observed for approximately three days.
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or the national competent authority via the national reporting system. See also section 16 of the package leaflet for contact details.
TRUSTED SOURCE
